Thermo Fisher Scientific Inc. (TMO) stock
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 10/3028% above fair value
$686.79−4.54 (-0.66%)
Close on Nov 17, 2026Market cap $254.47BP/E 36.2Yield 0.25%
Thermo Fisher Scientific operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Thermo Fisher Scientific's operating cash flow for the twelve months ending Sep 26, 2026 was $9.32B, up 21.9% year over year. For fiscal 2025 it was $7.82B, down 9.8% from the year before. Over ten years it grew 10.3% a year on average. The highest annual figure on record is $9.31B in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.82B | -9.8% |
| FY2024 | Dec 31, 2024 | $8.67B | +3.1% |
| FY2023 | Dec 31, 2023 | $8.41B | -8.2% |
| FY2022 | Dec 31, 2022 | $9.15B | -1.7% |
| FY2021 | Dec 31, 2021 | $9.31B | +12.3% |
| FY2020 | Dec 31, 2020 | $8.29B | +66.7% |
| FY2019 | Dec 31, 2019 | $4.97B | +9.5% |
| FY2018 | Dec 31, 2018 | $4.54B | +13.4% |
| FY2017 | Dec 31, 2017 | $4.01B | +22.9% |
| FY2016 | Dec 31, 2016 | $3.26B | +10.7% |
| FY2015 | Dec 31, 2015 | $2.94B | +12.3% |
| FY2014 | Dec 31, 2014 | $2.62B | +30.3% |
| FY2013 | Dec 31, 2013 | $2.01B | -1.4% |
| FY2012 | Dec 31, 2012 | $2.04B | +20.6% |
| FY2011 | Dec 31, 2011 | $1.69B | +12.9% |
| FY2010 | Dec 31, 2010 | $1.50B | -9.7% |
| FY2009 | Dec 31, 2009 | $1.66B | +16.8% |
| FY2008 | Dec 31, 2008 | $1.42B | -4.3% |
| FY2007 | Dec 31, 2007 | $1.48B | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 26, 2026 | $2.55B | +13.9% |
| Q2 FY2026 | Jun 27, 2026 | $2.13B | +51.9% |
| Q1 FY2026 | Mar 28, 2026 | $1.19B | +64.9% |
| Q4 FY2025 | Dec 31, 2025 | $3.46B | +5.1% |
| Q3 FY2025 | Sep 27, 2025 | $2.24B | +3.4% |
| Q2 FY2025 | Jun 28, 2025 | $1.40B | -28.6% |
| Q1 FY2025 | Mar 29, 2025 | $723.00M | -42.2% |
| Q4 FY2024 | Dec 31, 2024 | $3.29B | -11.6% |
| Q3 FY2024 | Sep 28, 2024 | $2.17B | -10.3% |
| Q2 FY2024 | Jun 29, 2024 | $1.96B | +27.3% |
| Q1 FY2024 | Mar 30, 2024 | $1.25B | +71.6% |
| Q4 FY2023 | Dec 31, 2023 | $3.72B | +6.8% |
| Q3 FY2023 | Sep 30, 2023 | $2.41B | +24.6% |
| Q2 FY2023 | Jul 1, 2023 | $1.54B | +0.8% |
| Q1 FY2023 | Apr 1, 2023 | $729.00M | -66.9% |
| Q4 FY2022 | Dec 31, 2022 | $3.49B | +41.9% |
| Q3 FY2022 | Oct 1, 2022 | $1.94B | -26.9% |
| Q2 FY2022 | Jul 2, 2022 | $1.53B | -31.4% |
| Q1 FY2022 | Apr 2, 2022 | $2.20B | +11.3% |
| Q4 FY2021 | Dec 31, 2021 | $2.46B | -26.4% |
| Q3 FY2021 | Oct 2, 2021 | $2.65B | -2.1% |
| Q2 FY2021 | Jul 3, 2021 | $2.23B | +18.1% |
| Q1 FY2021 | Apr 3, 2021 | $1.98B | +455.6% |
| Q4 FY2020 | Dec 31, 2020 | $3.34B | +74.5% |
| Q3 FY2020 | Sep 26, 2020 | $2.71B | +142.4% |
| Q2 FY2020 | Jun 27, 2020 | $1.89B | +45.7% |
| Q1 FY2020 | Mar 28, 2020 | $356.00M | -45.1% |
| Q4 FY2019 | Dec 31, 2019 | $1.91B | +6.2% |
| Q3 FY2019 | Sep 28, 2019 | $1.12B | -8.4% |
| Q2 FY2019 | Jun 29, 2019 | $1.29B | -10.4% |
| Q1 FY2019 | Mar 30, 2019 | $649.00M | +732.1% |
| Q4 FY2018 | Dec 31, 2018 | $1.80B | -3.5% |
| Q3 FY2018 | Sep 29, 2018 | $1.22B | +31.3% |
| Q2 FY2018 | Jun 30, 2018 | $1.44B | +70.1% |
| Q1 FY2018 | Mar 31, 2018 | $78.00M | -78.4% |
| Q4 FY2017 | Dec 31, 2017 | $1.87B | +54.8% |
| Q3 FY2017 | Sep 30, 2017 | $929.00M | – |
| Q2 FY2017 | Jul 1, 2017 | $849.00M | – |
| Q1 FY2017 | Apr 1, 2017 | $361.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.21B | – |
See a number that looks wrong?